Human E3 Ubiquitin-Protein Ligase CBL-C / CBL-3 (CBLC) Protein

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Human Cbl-c Protein is a recombinant protein from Human produced in Baculovirus-Insect Cells. A DNA sequence encoding the human CBLC (AAH28915.1) (Met1-Ala474) was expressed with the N-terminal polyhistidine-tagged GST tag at the N-terminus.
Documents del producto
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Cbl-c |
Host | Insect |
Origin | Human |
Observed MW | Molecular Weight: 80.2 kDa Sequence Fragment: Met1-Ala474 Tag: N-terminal His tag and GST tag Validity: The validity for this protein is 12 months. |
Expression | Recombinant |
Purity | > 95% (SDS-PAGE) |
Size 1 | 100 µg |
Form | |
Tested Applications | SDS-PAGE |
Buffer | Lyophilized from sterile 20mM Tris, 500mM Nacl, 10% glycerol, pH 8.0. |
Availability | Shipped within 5-15 working days. |
Storage | Aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
NCBI Accession | AAH28915.1 |
Alias | CBL-C,CBLC,RNF57,CBL-SL,CBL-3 |
Background | Protein CBLC |
Status | RUO |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
CBLC is a member of the CBL family of ubiquitin ligases. It functions similarly to CBL and CBLB in modulating receptor signaling through ubiquitination. CBLC is involved in regulating the endocytosis and degradation of RTKs by promoting the ubiquitination of specific substrates. This regulation is essential in controlling the intensity and duration of signaling pathways that govern cell growth and differentiation. CBLC also plays a role in immune system signaling, where its activity contributes to the fine-tuning of immune cell activation. Like other CBL family members, CBLC is implicated in various diseases, including cancer and immune disorders, due to its role in regulating key cellular processes.
Related Products

CBLC antibody
Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival.
Ver Producto
E3 Ubiquitin-Protein Ligase CBL-C (CBLC) Antibody
CBLC Antibody is a Rabbit Polyclonal Antibody against CBLC.
Ver Producto
E3 Ubiquitin-Protein Ligase CBL-C (CBLC) Antibody
CBLC proteins are a family of ubiquitin protein ligases (E3s) that negatively regulate signaling by targeting activated tyrosine kinases for degradation. Cbl c is the most recently cloned member of the Cbl proteins and is expressed only in epithelial cells (the other Cbl proteins are ubiquitously expressed). Cbl-c, like the other mammalian Cbl proteins, can ubiquitinate the activated EGFR and target it for degradation. Through interactions with proteins containing SRC homology-2 (SH2) and SH3 domains, CBL proteins modulate downstream cell signaling.
Ver Producto